11.32
전일 마감가:
$11.42
열려 있는:
$11.31
하루 거래량:
28,297
Relative Volume:
0.37
시가총액:
$798.30M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-8.27%
1개월 성능:
-10.30%
6개월 성능:
+0.00%
1년 성능:
+0.00%
Yd Bio Ltd Stock (YDES) Company Profile
YDES을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
YDES
Yd Bio Ltd
|
11.32 | 805.35M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Yd Bio Ltd 주식(YDES)의 최신 뉴스
YD Bio Limited Announces Directorate Changes - marketscreener.com
YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations. - Research Tree
YD Bio enters MOU to merge with EG BioMed in cancer diagnostics deal - Investing.com Australia
YD Bio enters MOU to merge with EG BioMed in cancer diagnostics deal By Investing.com - Investing.com South Africa
How an AI cancer test in Taipei hospitals could help shape future drugs - Stock Titan
YD Bio advances cancer detection and eye disease platforms By Investing.com - Investing.com Australia
YD Bio Limited entered into a Memorandum of Understanding to acquire EG BioMed Co., Ltd. - MarketScreener
YD Bio LtdPlans to evaluate up to three acquisitions in 2026 - marketscreener.com
Yd Bio LtdPlans To Evaluate Up To Three Acquisitions In 2026 - TradingView — Track All Markets
YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap - Yahoo Finance
Yd Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap - marketscreener.com
Micron and Lam Research among market cap stock movers on Tuesday By Investing.com - Investing.com India
YD Bio Limited Warrants (YDESW) Competitors - Meyka
YD Bio to establish California operations center for diagnostic development By Investing.com - Investing.com Australia
YD Bio to establish California operations center for diagnostic development - Investing.com India
YD Bio (Nasdaq: YDES) plans Calif. ops center for U.S. diagnostics - Stock Titan
YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center - Yahoo Finance
Assessing YD Bio (YDES) Valuation After a Sharp One-Month Share Price Rebound - simplywall.st
YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN - Finviz
YD Bio expands cancer detection platform to pancreatic and colorectal cancers - Investing.com Australia
YD Bio expands cancer detection platform to pancreatic and colorectal cancers By Investing.com - Investing.com South Africa
YD Bio Limited Expands OkaiDx™ Testing Portfolio to Pancreatic and Colorectal Cancer Detection Across the U.S. and Provides Clinical Research Update on Pancreatic Cancer Early Detection - Yahoo Finance
YD Bio (Nasdaq: YDES) widens OkaiDx to 44 states, shows 93.8% early pancreatic sensitivity - Stock Titan
YD Bio Limited (YDESW) stock historical prices and data - Yahoo Finance UK
Micron, Endeavour Silver, First Majestic Silver, Applied Digital And Other Big Stocks Moving Higher On Friday - Benzinga
Urban Outfitters, Arrowhead Pharmaceuticals, Petco Health and Wellness And Other Big Stocks Moving Higher On WednesdayArrowhead Pharma (NASDAQ:ARWR), Duolingo (NASDAQ:DUOL) - Benzinga
Tesla, Micron among market cap stock movers on Monday By Investing.com - Investing.com Australia
YD Bio stock rises after FDA clearance for eye care products - Investing.com Nigeria
YD Bio Stock Rises On Entry Into US Eye Care Segment - MSN
YD Bio receives FDA clearance for contact lenses and artificial tears - Investing.com India
Kyivstar Launches Starlink Direct to Cell Satellite Connectivity in Ukraine - The Manila Times
OMG Announces 28th Edition of Journal of Innovation - The Manila Times
Connect Biopharma to Present at the 8th Annual Evercore Healthcare Conference - The Manila Times
YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics - Yahoo Finance
YD Bio Limited (YDESW) Stock Historical Prices & Data - Yahoo! Finance Canada
YD Bio Limited (YDESW) company profile and facts - Yahoo Finance UK
[424B3] YD Bio Ltd Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan
[6-K] YD Bio Ltd Current Report (Foreign Issuer) | YDES SEC FilingForm 6-K - Stock Titan
YD Bio Limited Announces Board and Committee Changes - MarketScreener
S&P 500, Nasdaq and Dow Jones see big rise as heavyweight tech stocks witness rebound: Check top gainers a - The Economic Times
YD Bio (NASDAQ: YDES) opens U.S. OkaiDx RUO access via CLIA/CAP lab; 95.1% accuracy - Stock Titan
YD Bio and EG BioMed Expand U.S. Access to OkaiDx™, a cfDNA‑Methylation Blood Test for Post‑Treatment Breast Cancer Monitoring - Yahoo Finance
YD Bio plunges 52% after InvestingPro’s overvaluation warning By Investing.com - Investing.com Australia
YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES - The Manila Times
GYMD Showcases Industrial AI and Digitalization Strength at Tech Week Singapore 2025 - The Manila Times
20‑Year Exclusive Licenses — YD Bio Lists as YDES on Nasdaq to Scale cfDNA cancer tests and eye therapies - Stock Titan
YD Bio Limited (YDESW) Stock Price, News, Quote & History - Yahoo
YD Bio Ltd (YDES) latest press releases and corporate news - Yahoo
YD Bio Ltd (YDES) cash flow - Yahoo
YD Bio Ltd (YDES) Valuation Measures & Financial Statistics - Yahoo
Metals & Mining Virtual Investor Conference: Presentations Now Available for Online Viewing - The Manila Times
Yd Bio Ltd (YDES) 재무 분석
Yd Bio Ltd (YDES)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):